Please Read This Important Notice
Please be alert to potential fraudulent recruiting efforts, such as when an individual that is not associated with Acorda seeks to make contact with you by pretending to be (impersonating) someone from Acorda. Click here to read more.
You are now leaving the Acorda.com site. By clicking "Ok", you will be leaving this website (sponsored by Acorda Therapeutics, Inc.) to enter an external and entirely independent website.
Acorda.com provides this link as a service and assumes no responsibility for any information presented on external websites.
Acorda has acquired Biotie Therapies. We invite you to explore www.acorda.com to learn more about our company, including our continued development of BIotie clinical programs for tozadenant, SYN120 and BTT1023.